AU5769096A - Screening for inhibitors of tcr-mhc interactions - Google Patents

Screening for inhibitors of tcr-mhc interactions

Info

Publication number
AU5769096A
AU5769096A AU57690/96A AU5769096A AU5769096A AU 5769096 A AU5769096 A AU 5769096A AU 57690/96 A AU57690/96 A AU 57690/96A AU 5769096 A AU5769096 A AU 5769096A AU 5769096 A AU5769096 A AU 5769096A
Authority
AU
Australia
Prior art keywords
tcr
inhibitors
screening
mhc interactions
mhc
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU57690/96A
Inventor
Dan Hung Barouch
Bent Karsten Jakobsen
Stephen John Rupert Vessey
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Cancer Research Campaign Technology Ltd
Original Assignee
Cancer Research Campaign Technology Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cancer Research Campaign Technology Ltd filed Critical Cancer Research Campaign Technology Ltd
Publication of AU5769096A publication Critical patent/AU5769096A/en
Abandoned legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56966—Animal cells
    • G01N33/56977—HLA or MHC typing
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70503—Immunoglobulin superfamily
    • C07K14/7051—T-cell receptor (TcR)-CD3 complex
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70503—Immunoglobulin superfamily
    • C07K14/70539—MHC-molecules, e.g. HLA-molecules

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • Cell Biology (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Hematology (AREA)
  • Toxicology (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Virology (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
AU57690/96A 1995-05-16 1996-05-16 Screening for inhibitors of tcr-mhc interactions Abandoned AU5769096A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB9509844.8A GB9509844D0 (en) 1995-05-16 1995-05-16 Screening for inhibitors of TCR-MHC interactions
GB9509844 1995-05-16
PCT/GB1996/001165 WO1996036881A2 (en) 1995-05-16 1996-05-16 Screening for inhibitors of tcr-mhc interactions

Publications (1)

Publication Number Publication Date
AU5769096A true AU5769096A (en) 1996-11-29

Family

ID=10774510

Family Applications (1)

Application Number Title Priority Date Filing Date
AU57690/96A Abandoned AU5769096A (en) 1995-05-16 1996-05-16 Screening for inhibitors of tcr-mhc interactions

Country Status (3)

Country Link
AU (1) AU5769096A (en)
GB (1) GB9509844D0 (en)
WO (1) WO1996036881A2 (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0833941B1 (en) * 1995-04-07 2008-10-22 Cytogen Corporation Polypeptides having a functional domain of interest and methods of identifying and using same
US6309820B1 (en) 1995-04-07 2001-10-30 University Of North Carolina At Chapel Hill Polypeptides having a functional domain of interest and methods of identifying and using same
WO1997044667A2 (en) * 1996-05-21 1997-11-27 Institut Pasteur Method for using peptide complexes/major histocompatibility complex to obtain or purify antigen-specific t cells and to stimulate t cells
WO1999038526A1 (en) * 1998-01-29 1999-08-05 The Government Of The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Variant peptide ligands that selectively induce apoptosis
CA2410642A1 (en) * 2000-05-25 2001-11-29 Sunol Molecular Corporation Modulation of t-cell receptor interactions
WO2020028595A2 (en) * 2018-07-31 2020-02-06 Janux Therapeutics, Inc. Inhibitory t cell receptor peptides and discovery methods

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2106567A1 (en) * 1991-03-22 1992-09-23 William V. Williams Method of modulating mammalian t-cell response
PT735893E (en) * 1993-09-14 2009-03-06 Pharmexa Inc Pan dr-binding peptides for enhancement of the immune response

Also Published As

Publication number Publication date
WO1996036881A2 (en) 1996-11-21
GB9509844D0 (en) 1995-07-12
WO1996036881A3 (en) 1997-01-09

Similar Documents

Publication Publication Date Title
AU6174696A (en) Inhibitors of phospholipase a2
AU8256098A (en) Systems and methods for parallel synthesis of compounds
AU4915796A (en) Inhibitors of prenyl transferases
AU1035199A (en) Method for modification of cellulose
AU697649B2 (en) Pharmaceutical compositions and methods for modulating signal transduction
PL327569A1 (en) Promedications of thrombosin inhibitors
AU4875196A (en) Novel thrombin inhibitors
AU1301697A (en) Tyrosin-derivate as alpha-v-integrin inhibitors
AU7168696A (en) Inhibitors of regulatory pathways
AU4787596A (en) Thrombin inhibitors
AU6024196A (en) Inspection of edges
AU7497596A (en) Thrombin inhibitors
AU7264196A (en) Method of screening for factors that modulate gene expression
AU8245898A (en) Apparatus for sanitary packing of used objects
AU4704796A (en) Screening for modulators of biomolecules
AU5599598A (en) Inhibitors of glycosyltransferases
AU6692996A (en) Inhibitors of apoptosis
AU3661797A (en) Method for activation of bleaches
AU5381696A (en) Synthesis of bis-indolylmaleimides
AU6904596A (en) Method and construct for screening for inhibitors of transcriptional activation
AU4479096A (en) 5-methanesulfonamido-3h-isobenzofuran-1-ones as inhibitors of cyclooxygenase-2
AU2277597A (en) New inhibitors of sh2-mediated processes
AU5512096A (en) Method of inhibiting restenosis using calreticulin
AU6110496A (en) Phosphatase inhibitors
AU4128597A (en) Phosphatidylcholine synthesis inhibitors